ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank

The ApoE e4e4 genotype was associated with COVID-19 test positivity (odds ratio [OR] = 2.31,95% CI: 1.65-3.24, p = 1.19 · 10"6) (1) in the UK Biobank (UKB) cohort, during the epidemic peak in England, from March 16 to April 26,2020. With more COVID-19 test results (March 16 to May 31,2020) and...

Full description

Saved in:
Bibliographic Details
Published in:The journals of gerontology. Series A, Biological sciences and medical sciences Vol. 75; no. 9; pp. 1801 - 1803
Main Authors: Kuo, Chia-Ling, Pilling, Luke C, Atkins, Janice L, Masoli, Jane A H, Delgado, João, Kuchel, George A, Melzer, David
Format: Journal Article
Language:English
Published: US Oxford University Press 16-09-2020
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The ApoE e4e4 genotype was associated with COVID-19 test positivity (odds ratio [OR] = 2.31,95% CI: 1.65-3.24, p = 1.19 · 10"6) (1) in the UK Biobank (UKB) cohort, during the epidemic peak in England, from March 16 to April 26,2020. With more COVID-19 test results (March 16 to May 31,2020) and mortality data (to March 31,2020, with incomplete data for April 2020) linked to UKB, the ApoE e4 allele association with COVID-19 test positivity were reevaluated, and with all-cause mortality following test-confirmed COVID-19. Here, Kuo et al investigates the relation between the ApoE e4e4 genotype and mortality with COVID-19 in UK Biobank.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Commentary-1
ISSN:1079-5006
1758-535X
DOI:10.1093/gerona/glaa169